Provided by Tiger Trade Technology Pte. Ltd.

Myers

31.30
+0.53001.72%
Volume:12.43K
Turnover:387.87K
Market Cap:1.18B
PE:32.35
High:31.31
Open:31.25
Low:31.08
Close:30.77
52wk High:37.45
52wk Low:15.54
Shares:37.62M
Float Shares:36.71M
Volume Ratio:0.65
T/O Rate:0.03%
Dividend:0.54
Dividend Rate:1.73%
EPS(TTM):0.9677
EPS(LYR):0.9300
ROE:17.15%
ROA:7.63%
PB:3.84
PE(LYR):33.66

Loading ...

Bristol Myers price target raised to $82 from $75 at Piper Sandler

TIPRANKS
·
Yesterday

Myers Industries Keeps Quarterly Dividend at $0.135 a Share, Payable Oct. 5 to Shareholders of Record on Sept. 18

MT Newswires Live
·
Sep 09

Myers Industries Declares Quarterly Dividend of $0.135 a Share

Reuters
·
Sep 09

Myers Industries Sees Strong 2026 Infrastructure Growth, Moderate Gains in Industrial and Food Markets

Reuters
·
Sep 08

Bristol Myers’ arlocabtagene autoleucel shows positive results in Phase 2 trial

TIPRANKS
·
Sep 08

Myers Industries Divests Myers Tire Supply Business

TIPRANKS
·
Sep 01

Myers Industries Completes Sale of Myers Tire Supply

THOMSON REUTERS
·
Sep 01

Myers Industries management to meet virtually with KeyBanc

TIPRANKS
·
Sep 01

Bristol Myers presents results for EXPLORER-LTE cohort of MAVA-LTE study

TIPRANKS
·
Aug 31

Mastermyne Group (ASX:MYE) Shares Reflect Margin Gains But Legal Risks Linger

Simply Wall St.
·
Aug 26

Carrier Stock And 2 US Industrial Picks For Canada Tariff Substitution

Simply Wall St.
·
Aug 24

Investor backlash killed AstraZeneca, Bristol Myers tie-up, FT reports

TIPRANKS
·
Aug 12

C29 Metals Director James Myers Increases Shareholding via On‑Market Purchase

TIPRANKS
·
Aug 10

No $400B Mega Merger? AstraZeneca Rises, Bristol Myers Falls as Report Denies Deal

TIPRANKS
·
Aug 05

Best Buy downgraded, Bristol Myers upgraded: Wall Street’s top analyst calls

TIPRANKS
·
Aug 05

Bristol Myers, AstraZeneca not engaged in merger talks, Reuters reports

TIPRANKS
·
Aug 05

Market Chatter: AstraZeneca, Bristol Myers Not Pursuing Merger Talks

MT Newswires Live
·
Aug 05

AstraZeneca deal talks with Bristol Myers remain active, Semafor says

TIPRANKS
·
Aug 05

TD Cowen sees no strategic logic in an AstraZeneca-Bristol Myers merger

TIPRANKS
·
Aug 04

AstraZeneca-Bristol Myers Merger Buzz Puts Patent Expiration and Deal Economics in Focus

Benzinga
·
Aug 04